Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma-Reference-Cited by-同舟云学术

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

Published:2019-02-20 Issue:5 Volume:33 Page:1273-1277
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Goyal Gaurav^ORCID,Rajkumar S. Vincent,Lacy Martha Q.,Gertz Morie A.,Buadi Francis K.,Dispenzieri Angela,Hwa Yi L.,Fonder Amie L.,Hobbs Miriam A.,Hayman Suzanne R.,Zeldenrust Steven R.,Lust John A.,Russell Stephen J.,Leung Nelson^ORCID,Kapoor Prashant,Go Ronald S.^ORCID,Gonsalves Wilson I.,Kourelis Taxiarchis V.,Warsame Rahma,Kyle Robert A.,Kumar Shaji K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0419-7.pdf

Reference18 articles.

1. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–8.

2. Kristinsson SY, Anderson WF, Landgren O. Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. 2014;28:1346–8.

3. Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412–7.

4. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New Engl J Med. 2002;346:564–9.

5. Go RS, Gundrum JD, Neuner JM. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis. Clin Lymphoma Myeloma Leuk. 2015;15:177–186 e174.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of FLC tests in patients without other evidence of hematologic disorder;Clinical and Experimental Medicine;2024-08-24

2. Multiple myeloma;Nature Reviews Disease Primers;2024-06-27

3. Multiple myeloma incidence and mortality trends in the United States, 1999–2020;Scientific Reports;2024-06-24

4. Association of routine hematological parameters with the development of monoclonal gammopathies: a case-control study of 134,740 patients;Annals of Hematology;2024-06-06

5. Multiple myeloma incidence and mortality trends in the United States, 1999-2020;2024-05-06